AllerGen

Overview

The Allergy, Genes, and Environment Network NCE Inc. (AllerGen) was a national research network funded by Industry Canada through the Networks of Centres of Excellence (NCE) Program.
Health Research BC partnered with AllerGen to support early-career BC researchers through co-funded trainee awards, advancing innovative research on allergic diseases by combining provincial leadership with a strong national network.
AllerGen was established in response to the fact that one in three Canadians lived with allergic disease. Since its inception, AllerGen supported excellence in research and fostered commercialization, social innovation, and knowledge mobilization that enabled Canadians to better prevent, treat, and manage allergic diseases and asthma. This national network was made up of leading Canadian experts in allergy, asthma, anaphylaxis, and immune diseases with research expertise spanning biomedical, social, and natural sciences. These researchers worked in trans-disciplinary and multi-sectoral teams, collaborating nationally and internationally with stakeholders and partner organizations. They addressed gaps in knowledge and seized new opportunities in diagnostics, therapeutics, health care, public health, ethics, policy, clinical care, and patient education. AllerGen also trained the next generation of researchers, innovators, and clinician-scientists, while collaboratively working to reduce the morbidity, mortality, and socio-economic impacts of allergy, asthma, anaphylaxis, and related immune diseases.